Theravance sets up deal to sell rights to asthma drug to Royalty Pharma
[ad_1] Shares of Theravance Biopharma Inc. TBPH, -2.78% were up 13.8% in premarket trading on Thursday, the day after the company announced plans to sell the royalty rights to GlaxoSmithKline’s…